Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riess

Showing results (1361-1370 of 1,489) with videos related to

Pageof 149
Sort By:
Nature Communications|October 16, 2019
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2021
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter studyChristina Brinkmann, Mohamed Abdel-Wahab, Francesco Bedogni, et al.
Brain : a Journal of Neurology|January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathyMarcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
Targeted Oncology|December 16, 2016
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancerJean-Luc Van Laethem, Hanno Riess, Jacek Jassem, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Frontiers in Immunology|July 15, 2025
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant womenMadhuri S Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, et al.
Nature Communications|September 1, 2023
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M Monjazeb, Megan E Daly, Guillaume Luxardi, et al.
BMC Cancer|August 10, 2019
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive womenIlnaz Sepahi, Ulrike Faust, Marc Sturm, et al.
Neurobiology of Disease|February 29, 2024
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph diseaseMafalda Raposo, Jeannette Hübener-Schmid, Rebecca Tagett, et al.
Pageof 149

Showing results (1361-1370 of 1,489) with videos related to

Sort By:
Pageof 149
Nature Communications|October 16, 2019
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2021
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter studyChristina Brinkmann, Mohamed Abdel-Wahab, Francesco Bedogni, et al.
Brain : a Journal of Neurology|January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathyMarcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
Targeted Oncology|December 16, 2016
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancerJean-Luc Van Laethem, Hanno Riess, Jacek Jassem, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Frontiers in Immunology|July 15, 2025
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant womenMadhuri S Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, et al.
Nature Communications|September 1, 2023
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M Monjazeb, Megan E Daly, Guillaume Luxardi, et al.
BMC Cancer|August 10, 2019
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive womenIlnaz Sepahi, Ulrike Faust, Marc Sturm, et al.
Neurobiology of Disease|February 29, 2024
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph diseaseMafalda Raposo, Jeannette Hübener-Schmid, Rebecca Tagett, et al.
Pageof 149